60 related articles for article (PubMed ID: 27271776)
1. Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas.
Hilvo M; de Santiago I; Gopalacharyulu P; Schmitt WD; Budczies J; Kuhberg M; Dietel M; Aittokallio T; Markowetz F; Denkert C; Sehouli J; Frezza C; Darb-Esfahani S; Braicu EI
Cancer Res; 2016 Feb; 76(4):796-804. PubMed ID: 26685161
[TBL] [Abstract][Full Text] [Related]
2. Type-specific cell line models for type-specific ovarian cancer research.
Anglesio MS; Wiegand KC; Melnyk N; Chow C; Salamanca C; Prentice LM; Senz J; Yang W; Spillman MA; Cochrane DR; Shumansky K; Shah SP; Kalloger SE; Huntsman DG
PLoS One; 2013; 8(9):e72162. PubMed ID: 24023729
[TBL] [Abstract][Full Text] [Related]
3. Anaplastic Lymphoma Kinase Gene Rearrangement in Children and Young Adults With Mesothelioma.
Mian I; Abdullaev Z; Morrow B; Kaplan RN; Gao S; Miettinen M; Schrump DS; Zgonc V; Wei JS; Khan J; Pack S; Hassan R
J Thorac Oncol; 2020 Mar; 15(3):457-461. PubMed ID: 31783178
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine kinase gene rearrangements in epithelial malignancies.
Shaw AT; Hsu PP; Awad MM; Engelman JA
Nat Rev Cancer; 2013 Nov; 13(11):772-87. PubMed ID: 24132104
[TBL] [Abstract][Full Text] [Related]
5. The Impact of BRCA1 Expression on Survival Status in Ovarian Serous Carcinoma of Egyptian Patients.
Amin NH; Ahmed BA; Abou-Bakr AA; Eissa SS; Nassar HR; Gad M; Eissa M
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3613-3620. PubMed ID: 37898870
[TBL] [Abstract][Full Text] [Related]
6. ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature review.
Yang J; Dong L; Du H; Li XB; Liang YX; Liu GR
Diagn Pathol; 2019 Oct; 14(1):112. PubMed ID: 31627758
[TBL] [Abstract][Full Text] [Related]
7. Anaplastic lymphoma kinase overexpression enhances aggressive phenotypic characteristics of endometrial carcinoma.
Yokoi A; Nakamura Y; Hashimura M; Oguri Y; Matsumoto T; Nakagawa M; Ishibashi Y; Ito T; Ohhigata K; Harada Y; Fukagawa N; Saegusa M
BMC Cancer; 2023 Aug; 23(1):765. PubMed ID: 37592266
[TBL] [Abstract][Full Text] [Related]
8. Expression of Toll-like receptor 4 in ovarian serous adenocarcinoma and correlation with clinical stage and pathological grade.
Luo XZ; He QZ; Wang K
Int J Clin Exp Med; 2015; 8(8):14323-7. PubMed ID: 26550417
[TBL] [Abstract][Full Text] [Related]
9. Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex.
Chu YY; Chen MK; Wei Y; Lee HH; Xia W; Wang YN; Yam C; Hsu JL; Wang HL; Chang WC; Yamaguchi H; Jiang Z; Liu C; Li CF; Nie L; Chan LC; Gao Y; Wang SC; Liu J; Westin SN; Lee S; Sood AK; Yang L; Hortobagyi GN; Yu D; Hung MC
Nat Cancer; 2022 Oct; 3(10):1211-1227. PubMed ID: 36253486
[TBL] [Abstract][Full Text] [Related]
10. Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition.
Blessing AM; Santiago-O'Farrill JM; Mao W; Pang L; Ning J; Pak D; Bollu LR; Rask P; Iles L; Yang H; Tran S; Elmir E; Bartholomeusz G; Langley R; Lu Z; Bast RC
Cancer; 2020 Aug; 126(15):3579-3592. PubMed ID: 32484926
[TBL] [Abstract][Full Text] [Related]
11. Recurrent BCAM-AKT2 fusion gene leads to a constitutively activated AKT2 fusion kinase in high-grade serous ovarian carcinoma.
Kannan K; Coarfa C; Chao PW; Luo L; Wang Y; Brinegar AE; Hawkins SM; Milosavljevic A; Matzuk MM; Yen L
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1272-7. PubMed ID: 25733895
[TBL] [Abstract][Full Text] [Related]
12. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
Ramalingam P
Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
[TBL] [Abstract][Full Text] [Related]
13. [Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].
Devouassoux-Shisheboran M; Genestie C; Ray-Coquard I
Bull Cancer; 2016 Mar; 103(3):252-8. PubMed ID: 26853278
[TBL] [Abstract][Full Text] [Related]
14. Aberrant Expression of Anaplastic Lymphoma Kinase in Ovarian Carcinoma Independent of Gene Rearrangement.
Tang S; Yang F; Du X; Lu Y; Zhang L; Zhou X
Int J Gynecol Pathol; 2016 Jul; 35(4):337-47. PubMed ID: 27271776
[TBL] [Abstract][Full Text] [Related]
15. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
[TBL] [Abstract][Full Text] [Related]
16. Podocalyxin-like protein 1 expression and correlation with clinical characteristics in epithelial serous and mucinous ovarian carcinoma and tumor-like lesions.
Ye F; Hu Y; Zhou C; Hu Y; Chen H
Pathobiology; 2012; 79(6):307-13. PubMed ID: 22688257
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
